Quaker Chemical has rewarded patient shareholders over the past year, yet its longer track record has been far rougher, which puts fresh focus on whether the current share price lines up with the cash the business can realistically generate. With the stock recently closing at US$149.59 and sentiment influenced by stronger recent results, the key issue is how that price stacks up against an intrinsic value estimate based on its cash flows.
- Over the past 5 years the share price has declined 41.4%, which raises the question of whether the market has been reassessing the durability and quality of Quaker Chemical’s cash flows.
- More recently, stronger earnings and record profitability suggest the company may support higher free cash generation, which feeds directly into any Discounted Cash Flow (DCF) estimate.
- If you'd rather focus on earnings, this one's for you. See why Quaker Chemical's 26.4x P/E tells a different valuation story.
For investors, the debate is whether Quaker Chemical’s current market value is adequately backed by the cash flows implied in its Discounted Cash Flow (DCF) intrinsic value estimate.
If you are assessing whether Quaker Chemical’s current price is properly backed by its cash flows, it can help to compare it with other companies screened for 35 high quality undervalued stocks.
Is Quaker Chemical Fairly Priced on Cash Flow?
The Discounted Cash Flow (DCF) model here is built around Quaker Chemical’s ability to turn its operations into cash for shareholders. On the latest twelve month view, the business produced roughly $43.7 million of free cash flow, and the valuation framework expects this to shift into a phase of growing cash generation before levelling off into more modest, steady projections.
Those long range estimates point to free cash flow rising from the current base to higher annual levels over the next decade, then easing into slower growth as Quaker Chemical matures in the model. With the DCF output suggesting an intrinsic value broadly in line with the current share price of US$149.59, the stock appears priced as if that cash flow profile is achievable rather than requiring a stretch scenario. Because management just reported record adjusted EBITDA and better than expected Q3 2026 earnings, the stronger near term profitability helps explain why the market is valuing the shares close to the DCF outcome. Find out what Quaker Chemical could be worth using our Discounted Cash Flow (DCF) estimate.
The Quaker Chemical Narrative: What Would Justify Today's Price?
Simply Wall St Narratives pick up where the valuation puzzle for Quaker Chemical leaves off, by spelling out which paths for growth, profitability and earnings would need to play out for the shares to be worth materially more or materially less than today’s price. Each scenario ties its number to a concrete view of how Quaker Chemical’s revenue expansion, margin profile and key risks might evolve, giving you a reference point you can revisit as fresh information comes through.
One of the top community narratives on Quaker Chemical: 22% undervalued
"The main factor that needs to go right is successful execution of the multi year cost and business transformation program that targets at least $20 million to $30 million of structural savings and sustainably higher EBITDA margins…"
Discover why this Narrative puts Quaker Chemical at 22% undervalued.
Quaker Chemical's valuation still leaves one important issue hanging
Before drawing your own conclusion on Quaker Chemical, it is worth weighing the specific risk checks our research has flagged, because those signals can change how secure this price really feels. Take a closer look at 3 warning signs (1 major) before settling on a valuation.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com